FRAXIPARINE 9500IU Injection 0.3mlx2s

 686.40


Active Pharmaceutical Ingredient:
Drug Strength: 9500IU
Drug Form : Injection
Pack Size : 0.3mlx2s

Nadroparin (Ca):9500IU | Anticoagulants/Platelet deaggregators

Alternate brands of FRAXIPARINE 9500IU Injection 0.3mlx2s

Brand Name Price Savings
FRAXIPARINE 9500IU Injection 0.6mlx2s  977.60 You will pay -291.2 more
FRAXIPARINE 9500IU Injection 0.4mlx10s  4,243.20 You will pay -3556.8 more
FRAXIPARINE 9500IU Injection 0.8mlx2s  1,160.64 You will pay -474.24 more
List of alternate brands

Manufactured / Marketed By : GSK Product Form : InjectionPack Size : 0.3mlx2sIngredients : Nadroparin (Ca):9500IUGeneric Category : Anticoagulants/Platelet deaggregators

Reviews

There are no reviews yet.

Be the first to review “FRAXIPARINE 9500IU Injection 0.3mlx2s”

How it works

FRAXIPARINE 9500IU Injection 0.3mlx2s works by interfering with the normal clotting process and decreasing the clot forming ability of the blood.

Side effects

Major & minor side effects for FRAXIPARINE 9500IU Injection 0.3mlx2s

  • Injection site redness, bruising, or sores
  • Unusual bleeding or bruising
  • Dark red spots in the mouth
  • Bloody or coffee colored vomit severe
  • Black or tarry stools
  • Excessive menstrual bleeding
  • Dizziness and lightheadedness
  • Swelling of eyelids, face, lips, tongue severe
  • Difficulty in breathing severe
  • Difficulty in swallowing severe
  • Back pain rare
  • Muscle weakness rare
  • Fever
  • Burning or tingling sensation of skin

Uses of FRAXIPARINE 9500IU Injection 0.3mlx2s

What is it prescribed for?

  • Prophylaxis of ischemic complications in unstable angina

    This medicine is used to prevent the blockage of coronary arteries (major blood vessels carrying blood and oxygen to the heart) and associated complications. A blockage of the coronary artery may result in a heart attack, anginal pain, and heart rhythm abnormalities. This medicine is administered along with aspirin to prevent the complications.

  • Prophylaxis of venous thromboembolism during surgical procedures

    This medicine is used to prevent the formation of blood clots during major surgical procedures.

  • Venous thromboembolic events

    This medicine is used to treat and prevent the formation of blood clots in veins that could potentially break loose and migrate to larger veins in the legs or lungs, causing further complications.

  • Prophylaxis of clotting during hemodialysis sessions

    This medicine is used for the prevention of clot formation in the extracorporeal circulation during hemodialysis sessions that last more than 1 hour.

Concerns

Frequently asked questions

  • Onset of action

    The effect of this medicine can be observed within 2-3 hours of administration.

  • Duration of Effect

    The effect of this medicine lasts for an average duration of 16-18 hours.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is recommended for use in pregnant women only when absolutely necessary and the potential benefits outweigh the risks involved.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women since the safety and efficacy are not clinically established. Replacement with a suitable alternative should be done under your doctor's supervision.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to FRAXIPARINE 9500IU Injection 0.3mlx2s or any other inactive ingredient present along with it. Use of this medicine is also not recommended in patients having a known allergy to heparin or pork products.

  • Active major bleeding

    This medicine is not recommended for use in patients with a known heavy active bleeding due to the increased risk of worsening of the patient's condition.

  • Thrombocytopenia

    This medicine is not recommended for use in patients with an abnormally low platelet count due to the increased risk of excessive bleeding.

  • Hemorrhagic cardiovascular events

    This medicine is not recommended for use in patients who are at an increased risk of internal bleeding or hemorrhages due to the risk of worsening of the patient's condition.

  • Regional/local anesthesia

    This medicine is not recommended for use in patients with unstable angina, non-Q-wave myocardial infarction, or cancer who are undergoing regional anesthesia due to the increased risk of excessive bleeding.

  • Severe kidney damage

    This medicine is not recommended for use in patients having a severe impairment of kidney function due to the increased risk of worsening of the patient's condition.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is recommended for use in pregnant women only when absolutely necessary and the potential benefits outweigh the risks involved.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women since the safety and efficacy are not clinically established. Replacement with a suitable alternative should be done under your doctor's supervision.

General Warnings
  • Hemorrhage and risk factors

    Use of this medicine should be initiated only after internal bleeding or hemorrhage and associated risk factors are ruled out. All the underlying causes of bleeding such as peptic ulcer disease, hemophilia, impaired hemostasis, etc. should also be ruled out before the administration of this medicine.

  • Thrombocytopenia

    Use of this medicine may cause low levels of platelets (thrombocytopenia). It is advised to monitor the blood platelet levels at regular intervals while this medicine is administered. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

  • Benzyl alcohol as preservative

    Dosage forms containing benzyl alcohol as a preservative should not be administered to neonates, infants, pregnant or breastfeeding women. Benzyl alcohol may cause a fatal adverse event known as Gasping syndrome in neonates and infants.

  • Liver/kidney disease

    This medicine should be used with caution in patients having an impairment of normal liver/kidney function. Appropriate dose adjustments and frequent clinical monitoring are recommended for such patients. Replacement with a suitable alternative may be necessary based on the clinical condition.

  • Other medicines

    This medicine may interact with many other medicines and may cause severe side effects. Hence, you are advised to report the use of all medicines including herbs and supplements to the doctor before beginning treatment with this medicine.

  • Epidural/spinal/regional anesthesia

    This medicine should not be used in patients receiving regional, epidural, or spinal anesthesia due to the increased risk of excessive bleeding and formation of hematoma.

  • Interchangeability with other heparins

    This medicine should not be used interchangeably with other low molecular weight heparins.

Dosage

  • Missed Dose

    This medicine is usually administered in a clinical or hospital setup. However, if you are administering it at home and miss a scheduled dose, then call your doctor immediately for further instructions.

  • Overdose

    Seek emergency medical attention in case of an overdose or suspected overdose. Symptoms may include nosebleed, unusual bruising and bleeding, and the presence of blood in stool or urine.

Interactions

Interaction with Medicines
  • Clopidogrel severe
  • Escitalopram severe
  • Fluoxetine moderate
  • Mifepristone severe
  • Warfarin severe
  • Aspirin severe
  • Heparin severe
  • Diclofenac severe
  • Alteplase severe
  • Streptokinase severe
  • Dextran severe
  • Choline salicylate severe
Disease interactions
  • severe

    This medicine should be administered with extreme caution in patients suffering from hemophilia or other bleeding disorders due to the increased risk of excessive bleeding.

  • moderate

    This medicine should be administered with extreme caution in patients suffering from liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of liver function may be necessary based on the clinical condition.

  • severe

    This medicine should be administered with extreme caution in patients with peptic ulcer disease due to the increased risk of excessive bleeding.

  • severe

    This medicine should be administered with extreme caution in patients with retinopathy associated with high blood pressure and diabetes due to the increased risk of worsening of the patient's condition.

  • severe

    This medicine should be used with extreme caution in patients with subacute bacterial endocarditis, characterized by swelling of the heart walls or valves due to a bacterial infection, due to the risk of worsening of the patient's condition.

  • severe

    This medicine should be administered with extreme caution in patients suffering from kidney diseases due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments should be done based on the clinical condition.

  • severe

    This medicine is not recommended for use in patients having an uncontrolled high blood pressure. Therapy with this medicine should be started only after the hypertension is under control.

Food interactions
  • This medicine should be used with caution with fish oil or other food products containing omega-3 polyunsaturated fatty acids due to the increased risk of bleeding. Contact your doctor immediately if you experience any unusual bleeding or bruising, dizziness, weakness, and presence of blood in sputum/urine/stool. Your doctor/dietitian may suggest appropriate changes in your diet to avoid this interaction.

General Instructions

Administer FRAXIPARINE 0.4 ML PFS INJECTION exactly as instructed by the doctor. It should not be injected into the muscles. It is advised to administer this medicine under the supervision of a doctor in a clinical setup with regular monitoring of blood clotting time and other related parameters. Your doctor may ask you to undergo certain tests to determine the safety of use of this medicine.

Other details

  • Usage does not depend on food timings
  • To be taken as instructed by doctor
  • Does not cause sleepiness

References

Additional Information>

One of the following licensed pharmacy from the nearest location will deliver FRAXIPARINE 9500IU Injection 0.3mlx2s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Medicalstore.com.pk © All rights reserved

Made with ❤ by Dairah

Shopping Cart